NO20031928L - Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav - Google Patents

Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav

Info

Publication number
NO20031928L
NO20031928L NO20031928A NO20031928A NO20031928L NO 20031928 L NO20031928 L NO 20031928L NO 20031928 A NO20031928 A NO 20031928A NO 20031928 A NO20031928 A NO 20031928A NO 20031928 L NO20031928 L NO 20031928L
Authority
NO
Norway
Prior art keywords
preparation
methods
new crystal
ondansetron hydrochloride
solvate forms
Prior art date
Application number
NO20031928A
Other languages
English (en)
Other versions
NO20031928D0 (no
Inventor
Ramy Lidor-Hadas
Judith Aronhime
Revital Lifshitz
Shlomit Weizel
Valerie Niddam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031928D0 publication Critical patent/NO20031928D0/no
Publication of NO20031928L publication Critical patent/NO20031928L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO20031928A 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav NO20031928L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24428300P 2000-10-30 2000-10-30
US25381900P 2000-11-29 2000-11-29
US26553901P 2001-01-31 2001-01-31
PCT/US2001/048720 WO2002036558A2 (en) 2000-10-30 2001-10-30 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation

Publications (2)

Publication Number Publication Date
NO20031928D0 NO20031928D0 (no) 2003-04-29
NO20031928L true NO20031928L (no) 2003-06-27

Family

ID=27399743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031928A NO20031928L (no) 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav

Country Status (20)

Country Link
US (1) US20020107275A1 (no)
EP (1) EP1339707A2 (no)
JP (1) JP2004525083A (no)
KR (1) KR20030042038A (no)
CN (1) CN1498216A (no)
AU (1) AU2002230935A1 (no)
CA (1) CA2426026A1 (no)
CZ (1) CZ20031397A3 (no)
DE (1) DE01991193T1 (no)
ES (1) ES2204358T1 (no)
HR (1) HRP20030432A2 (no)
HU (1) HUP0401239A2 (no)
IL (1) IL155644A0 (no)
IS (1) IS6797A (no)
MX (1) MXPA03003761A (no)
NO (1) NO20031928L (no)
PL (1) PL366150A1 (no)
SK (1) SK6182003A3 (no)
WO (1) WO2002036558A2 (no)
YU (1) YU32003A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156835A0 (en) * 2001-01-11 2004-02-08 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
KR20040104654A (ko) 2002-04-29 2004-12-10 비오갈 기오기스제르갸르 알티. 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카르바졸-4-온의 제조 방법
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o
ES2533563T5 (es) * 2006-01-27 2018-07-24 Adare Pharmaceuticals, Inc. Sistemas de suministro de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos
EP1976491B1 (en) * 2006-01-27 2014-12-17 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
EP2099298A4 (en) * 2006-12-07 2010-01-06 Helsinn Healthcare Sa CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
MA39033A1 (fr) 2013-11-15 2017-11-30 Akebia Therapeutics Inc Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) * 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
KR20040104654A (ko) * 2002-04-29 2004-12-10 비오갈 기오기스제르갸르 알티. 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카르바졸-4-온의 제조 방법
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법

Also Published As

Publication number Publication date
PL366150A1 (en) 2005-01-24
CN1498216A (zh) 2004-05-19
SK6182003A3 (en) 2004-03-02
KR20030042038A (ko) 2003-05-27
IL155644A0 (en) 2003-11-23
HRP20030432A2 (en) 2004-06-30
DE01991193T1 (de) 2004-07-08
NO20031928D0 (no) 2003-04-29
EP1339707A2 (en) 2003-09-03
ES2204358T1 (es) 2004-05-01
YU32003A (sh) 2006-05-25
WO2002036558A2 (en) 2002-05-10
AU2002230935A1 (en) 2002-05-15
WO2002036558A3 (en) 2003-02-06
IS6797A (is) 2003-04-29
MXPA03003761A (es) 2003-07-28
CA2426026A1 (en) 2002-05-10
US20020107275A1 (en) 2002-08-08
JP2004525083A (ja) 2004-08-19
HUP0401239A2 (hu) 2004-12-28
CZ20031397A3 (cs) 2003-11-12

Similar Documents

Publication Publication Date Title
NO20055211D0 (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1227088T3 (da) Krystallinsk base af citalopram og hydrochlorid- eller hydrobromidsaltet deraf
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
NO20014504L (no) Anordning og fremgangsmåte for rehabilitering av tinnitus
IS2599B (is) 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólín og lyfjafræðilega viðurkenndar afleiður þess
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
IS6477A (is) Afleiður piperazíns og piperadíns
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
IS2654B (is) Essítalópram hýdróbrómíð og aðferð til framleiðslu þess
NO20031928L (no) Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav
NO20040266L (no) Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav
NO20033251D0 (no) Fremgangsmåte for bestemmelse av den effektive mobilitet og permeabilitet for en formasjon på stedet
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO20032440L (no) Fremgangsmåte for fremstillingen av iopamidol og de nye intermediater deri
NO20025069L (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
NO20030822L (no) Nye forbindelser og fremgangsmåter
PL365272A1 (en) Method and device for fabrication of foundation element
NO20035331D0 (no) Nye heterocyklisk forbindelse og medisinsk anvendelse derav
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
NO20030414L (no) Fremgangsmåte for fremstilling av brönnsement og tilhörende testanordning
NO20042810L (no) Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application